JPWO2019204643A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019204643A5
JPWO2019204643A5 JP2021506378A JP2021506378A JPWO2019204643A5 JP WO2019204643 A5 JPWO2019204643 A5 JP WO2019204643A5 JP 2021506378 A JP2021506378 A JP 2021506378A JP 2021506378 A JP2021506378 A JP 2021506378A JP WO2019204643 A5 JPWO2019204643 A5 JP WO2019204643A5
Authority
JP
Japan
Prior art keywords
gene
seq
domain
terminus
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021506378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523733A (ja
JP2021523733A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/028174 external-priority patent/WO2019204643A2/en
Publication of JP2021523733A publication Critical patent/JP2021523733A/ja
Publication of JPWO2019204643A5 publication Critical patent/JPWO2019204643A5/ja
Publication of JP2021523733A5 publication Critical patent/JP2021523733A5/ja
Priority to JP2024198757A priority Critical patent/JP2025037883A/ja
Pending legal-status Critical Current

Links

JP2021506378A 2018-04-18 2019-04-18 動物病原体由来ポリペプチドおよびその遺伝子工学的利用 Pending JP2021523733A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024198757A JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862659656P 2018-04-18 2018-04-18
US62/659,656 2018-04-18
US201862690905P 2018-06-27 2018-06-27
US62/690,905 2018-06-27
US201862716223P 2018-08-08 2018-08-08
US62/716,223 2018-08-08
US201862738825P 2018-09-28 2018-09-28
US62/738,825 2018-09-28
US201962819237P 2019-03-15 2019-03-15
US62/819,237 2019-03-15
PCT/US2019/028174 WO2019204643A2 (en) 2018-04-18 2019-04-18 Animal pathogen-derived polypeptides and uses thereof for genetic engineering

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024198757A Division JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Publications (3)

Publication Number Publication Date
JP2021523733A JP2021523733A (ja) 2021-09-09
JPWO2019204643A5 true JPWO2019204643A5 (https=) 2022-04-20
JP2021523733A5 JP2021523733A5 (https=) 2022-04-20

Family

ID=68240638

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021506378A Pending JP2021523733A (ja) 2018-04-18 2019-04-18 動物病原体由来ポリペプチドおよびその遺伝子工学的利用
JP2024198757A Pending JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024198757A Pending JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Country Status (6)

Country Link
US (2) US12312383B2 (https=)
EP (1) EP3781193A4 (https=)
JP (2) JP2021523733A (https=)
AU (1) AU2019256517B2 (https=)
CA (1) CA3097648A1 (https=)
WO (1) WO2019204643A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4010004A4 (en) * 2019-08-07 2023-09-13 Altius Institute For Biomedical Sciences Compositions and methods for modulation of gene expression
JP7507242B2 (ja) * 2020-08-25 2024-06-27 中興通訊股▲ふん▼有限公司 無線ネットワーク一時識別子に関連する方法および装置
AU2021392032A1 (en) 2020-12-03 2023-06-22 Century Therapeutics, Inc. Genetically engineered cells and uses thereof
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
AR124414A1 (es) 2020-12-18 2023-03-22 Century Therapeutics Inc Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
WO2025034754A2 (en) * 2023-08-08 2025-02-13 Altius Institute For Biomedical Sciences Nucleic acid binding domains and methods of use thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140474D1 (de) * 2000-09-08 2009-12-24 Univ Zuerich Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
US20110239315A1 (en) * 2009-01-12 2011-09-29 Ulla Bonas Modular dna-binding domains and methods of use
JP5866283B2 (ja) 2009-07-28 2016-02-17 サンガモ バイオサイエンシーズ， インコーポレイテッド トリヌクレオチド反復疾患を治療するための方法および組成物
HUE041436T2 (hu) 2009-12-10 2019-05-28 Univ Minnesota Tal-effektor-közvetített DNS-módosítás
EP2534163B1 (en) 2010-02-09 2015-11-04 Sangamo BioSciences, Inc. Targeted genomic modification with partially single-stranded donor molecules
JP6208580B2 (ja) 2010-05-17 2017-10-04 サンガモ セラピューティクス， インコーポレイテッド 新規のｄｎａ結合タンパク質及びその使用
US9499592B2 (en) 2011-01-26 2016-11-22 President And Fellows Of Harvard College Transcription activator-like effectors
WO2012168304A1 (en) 2011-06-07 2012-12-13 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Protein having nuclease activity, fusion proteins and uses thereof
CA2841710C (en) 2011-07-15 2021-03-16 The General Hospital Corporation Methods of transcription activator like effector assembly
WO2013015220A1 (ja) 2011-07-22 2013-01-31 株式会社東芝 Ｘ線診断装置及び制御プログラム
AU2012312260B2 (en) 2011-09-21 2017-08-31 Sangamo Therapeutics, Inc. Methods and compositions for regulation of transgene expression
AU2012340213B2 (en) 2011-11-16 2017-12-07 Sangamo Therapeutics, Inc. Modified DNA-binding proteins and uses thereof
US8450107B1 (en) 2011-11-30 2013-05-28 The Broad Institute Inc. Nucleotide-specific recognition sequences for designer TAL effectors
DK3141259T3 (da) 2012-03-15 2019-09-30 Cellectis Repeat-variable direster til targeting af nukleotider
WO2013152220A2 (en) * 2012-04-04 2013-10-10 Life Technologies Corporation Tal-effector assembly platform, customized services, kits and assays
US20140230083A1 (en) * 2012-07-24 2014-08-14 Cellectis Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
DK2893022T3 (da) 2012-09-04 2020-07-27 Scripps Research Inst Kimæriske polypeptider med målrettet bindingsspecificitet
US9181535B2 (en) 2012-09-24 2015-11-10 The Chinese University Of Hong Kong Transcription activator-like effector nucleases (TALENs)
WO2014071219A1 (en) 2012-11-01 2014-05-08 Factor Bioscience Inc. Methods and products for expressing proteins in cells
ES2778033T3 (es) 2012-11-16 2020-08-07 Poseida Therapeutics Inc Enzimas específicas de sitio y métodos de uso
US9708589B2 (en) 2012-12-18 2017-07-18 Monsanto Technology Llc Compositions and methods for custom site-specific DNA recombinases
US20150376585A1 (en) 2013-02-01 2015-12-31 Cellectis Tevi chimeric endonuclease and their preferential cleavage sites
KR102251168B1 (ko) 2013-10-25 2021-05-13 셀렉티스 고 반복 모티프를 포함하는 dna 서열에 대한 효율적이고 특이적인 표적화를 위한 희소-절단 엔도뉴클레아제의 설계
US9850497B2 (en) 2013-11-04 2017-12-26 Regents Of The University Of Minnesota Gene targeting methods and tools
WO2015164748A1 (en) 2014-04-24 2015-10-29 Sangamo Biosciences, Inc. Engineered transcription activator like effector (tale) proteins
US10612011B2 (en) 2015-07-30 2020-04-07 President And Fellows Of Harvard College Evolution of TALENs
US11353400B2 (en) 2016-07-19 2022-06-07 Altius Institute For Biomedical Sciences Methods for fluorescence imaging microscopy and Nano-FISH
CN110312799A (zh) 2016-08-17 2019-10-08 博德研究所 新型crispr酶和系统
SG10201913948PA (en) 2016-08-24 2020-03-30 Sangamo Therapeutics Inc Engineered target specific nucleases
AU2018221730B2 (en) 2017-02-15 2024-06-20 Novo Nordisk A/S Donor repair templates multiplex genome editing
US12264181B2 (en) 2018-06-27 2025-04-01 Altius Institute For Biomedical Sciences Nucleic acid binding domains and methods of use thereof
WO2020006131A2 (en) 2018-06-27 2020-01-02 Altius Institute For Biomedical Sciences Nucleases for genome editing

Similar Documents

Publication Publication Date Title
JP2021523733A5 (https=)
US10527609B2 (en) Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
Kozmik et al. Alternatively spliced insertions in the paired domain restrict the DNA sequence specificity of Pax6 and Pax8
Virbasius et al. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis.
KR100659922B1 (ko) Ｇｎｎ에 대한 아연 핑거 결합 도메인
US7223556B1 (en) Targeted proteolysis by recruitment to ubiquitin protein ligases
US6881825B1 (en) Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues
EP3747999B1 (en) Dna modifying fusion proteins and methods of use thereof
EP2443155B1 (en) Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1 (mtm1) polypeptides
JP2020520654A5 (https=)
KR20120036947A (ko) 성장 호르몬 폴리펩타이드 및 이를 제조하고 사용하는 방법
EP3814493A1 (en) Nucleic acid binding domains and methods of use thereof
US6800457B2 (en) Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
WO1996006110A1 (en) Composite dna-binding proteins and materials and methods relating thereto
JPWO2019204643A5 (https=)
US20100143972A1 (en) Method of Making Cyclic Polypeptides with Inteins
Caradonna et al. The Nature of Enzymes Involved in Uracil-DNA Repair: Isoform Charac-teristics of Proteins Responsible for Nuclear and Mitochondrial Genomic Integrity 1
JP2013527752A (ja) 融合ポリペプチドｈｐｖ抗原を用いたｈｐｖ抗体スクリーニング方法
US7033770B2 (en) Human wingless-like gene
JP5371306B2 (ja) 負の超らせんｄｎａ結合ドメイン
ES2351685T3 (es) Proteína similar a la proteína específica neuroendocrina y adnc codificante.
ES2271013T3 (es) Ligando de proteina que se fija al calcio por induccion neuronal aguda de tipo 1.
US20040152195A1 (en) Vector for introducing molecules in eukaryotic cells and molecules vectorised by same
GENE HUMAN SUPEROXIDE DISMUTASE CDNA
JP2003523748A (ja) 新規ホスホジエステラーゼ７ｂ型